What is an ANDA: Abbreviated New Drug Application Explained
Learn what an ANDA is and how it enables generic drugs to reach the market. We explain the FDA approval process, bioequivalence requirements, and the economic impact on prescription costs.
Long-term follow-up: sustaining health after switching to generics
Explore the realities of long-term health after switching to generic medications. Learn about bioequivalence gaps, manufacturing risks, and strategies to maintain stability.
Why Some Brand-Name Drugs Have No Generic Alternatives
Many brand-name drugs still have no generic versions even after patents expire due to complex manufacturing, patent tactics, and regulatory barriers. This explains why some medications remain expensive for years.
